{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:20:03Z","timestamp":1792120803611,"version":"4.4.0"},"reference-count":44,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T00:00:00Z","timestamp":1672963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010412","name":"Janssen Global Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Hematology"],"published-print":{"date-parts":[[2023,12,31]]},"DOI":"10.1080\/16078454.2022.2157581","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T14:14:09Z","timestamp":1673014449000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":14,"title":["Assessing the prognostic utility of hematologic response for overall survival in patients with newly diagnosed AL amyloidosis: results of a meta-analysis"],"prefix":"10.1080","volume":"28","author":[{"given":"Efstathios","family":"Kastritis","sequence":"first","affiliation":[{"name":"Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpit","family":"Misra","sequence":"additional","affiliation":[{"name":"Cytel, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Gurskyte","sequence":"additional","affiliation":[{"name":"Cytel, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florint","family":"Kroi","sequence":"additional","affiliation":[{"name":"Cytel, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Verhoek","sequence":"additional","affiliation":[{"name":"Cytel, Rotterdam, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Vermeulen","sequence":"additional","affiliation":[{"name":"Janssen Research &amp; Development, LLC, Leiden, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ammann","sequence":"additional","affiliation":[{"name":"Janssen Global Services, LLC, Raritan, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Lam","sequence":"additional","affiliation":[{"name":"Janssen Global Services, LLC, Raritan, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cote","sequence":"additional","affiliation":[{"name":"Janssen Global Services, LLC, Raritan, NJ, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashutosh D.","family":"Wechalekar","sequence":"additional","affiliation":[{"name":"National Amyloidosis Centre, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,1,6]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13169"},{"key":"e_1_3_4_3_1","first-page":"45","article-title":"Primary systemic amyloidosis: clinical and laboratory features in 474 cases","volume":"32","author":"Kyle RA","year":"1995","unstructured":"Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol. 1995;32:45\u201359.","journal-title":"Semin Hematol"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000454"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.100"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0034-3"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-015-0250-0"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-629790"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-013-0175-0"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-620302"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1159\/000508287"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/13506129.2015.1102131"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-12-473066"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25819"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-020-00354-7"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070484"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.12.021"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.213900"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-08-662726"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028631"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23936"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.06.018"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1080\/13506129.2020.1798224"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13500"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-07-099481"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11413"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.2217\/cer-2021-0261"},{"key":"e_1_3_4_28_1","unstructured":"National Institute for Health and Care Excellence. (2015). Single technology appraisal: user guide for company evidence submission template [cited 2021 Dec 14]. Available from: https:\/\/www.nice.org.uk\/process\/pmg24\/chapter\/clinical-effectiveness#quality-assessment-of-the-relevant-clinical-effectiveness-evidence."},{"key":"e_1_3_4_29_1","unstructured":"Wells GA Shea B O\u2019Connell D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses [cited 2021 Dec 14]. Available from: http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp."},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-9"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d4002"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.37.7614"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.104109"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2013.095463"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12558"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00510-7"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.178095"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21114129"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.12691\/ijhd-1-1A-4"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0480"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-140708"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-152675"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-137582"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/16078454.2022.2157581","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T12:05:39Z","timestamp":1702296339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/16078454.2022.2157581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,6]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12,31]]}},"alternative-id":["10.1080\/16078454.2022.2157581"],"URL":"https:\/\/doi.org\/10.1080\/16078454.2022.2157581","relation":{},"ISSN":["1607-8454"],"issn-type":[{"value":"1607-8454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,6]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhem20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=yhem20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-06","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2157581"}}